Jiayi Xu

This inventor holds 15 USPTO granted patents and 6 published patent applications and 15 EPO patents, primarily in JAK2 Inhibitors. Top assignees: Merck Sharp + Dohme Corp., Ajax Therapeutics, Inc., Mochida Pharmaceutical Co., Ltd.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiayi Xu. Retrieved from https://idiyas.com/inventor/jiayi-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 15 (Patent Applications = 14)

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Edison, NJ (US) (2017 - 2019)
Marlboro, NJ (US) (2016 - 2024)

Company Filing History:

10 out of 2,405

Merck Sharp + Dohme Corp.

patents

5 out of 5

Ajax Therapeutics, Inc.

patents

3 out of 229

Mochida Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

JAK2 Inhibitors

Factor IXa Inhibitors

Factor XIa Inhibitors

Glucokinase Activators

Isoquinoline Derivatives

Macrocyclic Compounds

Pyridinecarboxamide Derivatives

Pharmaceutical Compositions

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275717 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2025-04-14),

2. 12162881 - Forms and compositions of inhibitors of JAK2 (2024-12-10),

3. 12043632 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2024-07-23),

4. 11970494 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2024-04-30),

5. 11691963 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2023-07-04),

6. 10351558 - Factor IXa inhibitors (2019-07-16),

7. 10344039 - Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their use (2019-07-09),

8. 10214512 - Factor XIA inhibitors (2019-02-26),

9. 10093683 - Factor XIa inhibitors (2018-10-09),

10. 10065945 - Isoquinoline derivatives as MGAT2 inhibitors (2018-09-04),

11. 9969724 - Factor IXa inhibitors (2018-05-15),

12. 9808445 - Factor IXa inhibitors (2017-11-07),

13. 9708308 - Factor IXa inhibitors (2017-07-18),

14. 9527838 - 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment (2016-12-27),

15. 9453038 - Glucokinase activator compounds, compositions containing such compounds, and methods of treatment (2016-09-27),

Title: The Innovative Mind of Jiayi Xu

Introduction: Jiayi Xu, a talented inventor hailing from Marlboro, NJ (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jiayi Xu has recently been granted several patents for his cutting-edge inventions in the realm of artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Jiayi Xu has established himself as a visionary in the tech industry, leading teams to develop revolutionary products that have reshaped the way we interact with technology.

Collaborations: Throughout his career, Jiayi Xu has collaborated with top research institutions, universities, and leading tech companies to bring his ideas to life. His collaborative spirit has led to the successful implementation of numerous innovative projects.

Conclusion: Jiayi Xu's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.